In the last 12 months, insiders at Hepion Pharmaceuticals, Inc. ($HEPA) filed 5 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
Hepion Pharmaceuticals, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- BRANCACCIO JOHN P (Chairman) — 1 transaction totaling $0
- Purcell Michael J. (Director) — 1 transaction totaling $0
- Lbiati Kaouthar (Director) — 1 transaction totaling $0
- Block Timothy M. (Director) — 1 transaction totaling $0
- JACOB GARY S (Director) — 1 transaction totaling $0
View all SEC Filings for Hepion Pharmaceuticals, Inc. (HEPA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2024 | Purcell Michael J. | Director | A | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 19, 2024 | Block Timothy M. | Director | A | Stock Options | 85000 | $0.00 | 99,562.0000 | 0 | 583.71% | 0.00% |
| Feb. 19, 2024 | JACOB GARY S | Director | A | Stock Options | 85000 | $0.00 | 102,120.0000 | 0 | 496.50% | 0.00% |
| Feb. 19, 2024 | Lbiati Kaouthar | Director | A | Stock Options | 85000 | $0.00 | 88,000.0000 | 0 | 2833.33% | 0.00% |
| Feb. 19, 2024 | BRANCACCIO JOHN P | Chairman | A | Stock Options | 85000 | $0.00 | 99,563.0000 | 0 | 583.67% | 0.00% |